I obtained a PhD degree in Molecular Biomedicine at the Spanish National Cancer Research Centre (Madrid, Spain), where I studied the role of cell competition in carcinogenesis using chemical and genetic mouse models of cancer. In 2011, I was awarded a Marie Curie postdoctoral fellowship within the EuroCancerStemCell training network. It allowed me to carry out a collaborative research project at Xentech (Evry, France), as a result of which I identified a novel marker of chemotherapy-resistant human breast cancer cells. From 2013 to 2017, I worked as a postdoctoral researcher at the Viral Genomics and Vaccination Unit in Pasteur Institute (Paris, France), where I developed a genome-wide screening assay for identification of Flavivirus host cell replication factors.

In 2018, I was recruited as a postdoctoral researcher at the laboratory of Genetic Skin Diseases at Imagine Institute in order to characterize a mouse model of Netherton syndrome and to optimize it for pre-clinical testing of novel candidate therapeutics. Since then, I have also been involved in other projects, which aim to decipher the molecular mechanisms of Netherton syndrome using both mouse models and patient samples.